Should pregnant women with diabetes be counseled differently if nephropathy was detected? a population database study.
Sarah AldhaheriHaitham A BaghlafAhmad BadeghieshMichael H DahanPublished in: The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians (2022)
Diabetic nephropathy is associated with increased obstetrical and perinatal morbidity compared to diabetes mellitus alone. These patients may benefit from a high dose of folic acid, more vigilant antenatal surveillance, delivery in a tertiary care center, and more rigorous screening and prevention methods for pregnancy-induced hypertension diseases at antenatal care visits.
Keyphrases
- pregnant women
- diabetic nephropathy
- high dose
- tertiary care
- preterm birth
- pregnancy outcomes
- end stage renal disease
- type diabetes
- blood pressure
- healthcare
- newly diagnosed
- ejection fraction
- public health
- cardiovascular disease
- chronic kidney disease
- glycemic control
- palliative care
- low dose
- prognostic factors
- high glucose
- quality improvement
- stem cell transplantation
- diabetic rats
- oxidative stress
- endothelial cells
- adipose tissue
- electronic health record
- health insurance